22.418 makale bulundu

4-siklopropilmetoksi-n-(3,5-dikloro-1-oksidopiridin-4-il)-5-(metoksi)piridin-2-karboksidin parkinson hastalığı ile ilgili motor bozukluklarının tedavisi için kullanılması

Use of 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxidopyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide for the treatment of motor disorders related to parkinson's disease

PHILIPPE DELAY-GOYET, CLAIRE DELGORGE, CHRISTINE MENET, GILLES POUGHON, CHRISTINE RAVINET-TRILLOU.

· 2008-04-16

4-CYCLOPROPYLMETHOXY-N-(3.5-DICHLORO-1-OXIDOPYRIDIN-4-YL)-5-(METHOXY)PYRIDINE-2-CARBOXAMIDE'NİN PARKINSON'UN HASTALIKLARINA İLGİLİ ARAŞTIRMASI İÇİN KULLANIMI

USE OF 4-CYCLOPROPYLMETHOXY-N-(3,5-DICHLORO-1-OXIDOPYRIDIN-4-YL)-5-(METHOXY)PYRIDINE-2-CARBOXAMIDE FOR THE TREATMENT OF MOTOR DISORDERS RELATED TO PARKINSON'S DISEASE

DELAY GOYET PHILIPPE, DELGORGE CLAIRE, MENET CHRISTINE, POUGHON GILLES, RAVINET TRILLOU CHRISTINE.

· 2008-04-16

4-CYCLOPROPYLMETHOXY-N-(3.5-DICHLORO-1-OXIDOPYRIDIN-4-YL)-5-(METHOXY)PYRIDINE-2-CARBOXAMIDE'NİN PARKINSON'UN HASTALIKLARINA İLGİLİ ARAŞTIRMASI İÇİN KULLANIMI

USE OF 4-CYCLOPROPYLMETHOXY-N-(3,5-DICHLORO-1-OXIDOPYRIDIN-4-YL)-5-(METHOXY)PYRIDINE-2-CARBOXAMIDE FOR THE TREATMENT OF MOTOR DISORDERS RELATED TO PARKINSON'S DISEASE

MENET CHRISTINE, DELGORGE CLAIRE, DELAY-GOYET PHILIPPE, POUGHON GILLES, RAVINET-TRILLOU CHRISTINE.

· 2008-04-16

PARKINSON'UN HASTALIKLARININ ÖNCEKİ TEDAVİSİ İÇİN 2-AMINOTETRALINES

SUBSTITUTED 2-AMINOTETRALINES FOR THE PREVENTIVE TREATMENT OF PARKINSON'S DISEASE

SCHELLER DIETER, DRESSEN FRANK.

· 2008-04-16

4-siklopropilmetoksi-N-(3,5-dikloro-1-oksidopiridin-4-il)-5-(metoksi)piridin-2-karboksidemidin parkinson hastalığı ile ilgili motor bozukluklarının tedavisi için kullanılması

Use of 4-cyclopropylmethoxy-N--(3,5-dichloro-1-oxidopyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide for the treatment of motor disorders related to parkinson's disease

MENET CHRISTINE, POUGHON GILLES, RAVINET-TRILLOU CHRISTINE, DELAY-GOYET PHILIPPE, DELGORGE CLAIRE.

· 2008-04-16

4-CYCLOPROPYLMETHOXY-N-(3.5-DICHLORO-1-OXIDOPYRIDIN-4-YL)-5-(METHOXY)PYRIDINE-2-CARBOXAMIDE'NİN PARKINSON'UN HASTALIKLARINA İLGİLİ ARAŞTIRMASI İÇİN KULLANIMI

USE OF 4-CYCLOPROPYLMETHOXY-N-(3,5-DICHLORO-1-OXIDOPYRIDIN-4-YL)-5-(METHOXY)PYRIDINE-2-CARBOXAMIDE FOR THE TREATMENT OF MOTOR DISORDERS RELATED TO PARKINSON'S DISEASE

DELAY-GOYET PHILIPPE, DELGORGE CLAIRE, MENET CHRISTINE, POUGHON GILLES, RAVINET-TRILLOU CHRISTINE.

· 2008-04-16

4-CYCLOPROPYLMETHOXY-N-(3.5-DICHLORO-1-OXIDOPYRIDIN-4-YL)-5-(METHOXY)PYRIDINE-2-CARBOXAMIDE'NİN PARKINSON'UN HASTALIKLARINA İLGİLİ ARAŞTIRMASI İÇİN KULLANIMI

USE OF 4-CYCLOPROPYLMETHOXY-N-(3,5-DICHLORO-1-OXIDOPYRIDIN-4-YL)-5-(METHOXY)PYRIDINE-2-CARBOXAMIDE FOR THE TREATMENT OF MOTOR DISORDERS RELATED TO PARKINSON'S DISEASE

DELAY-GOYET PHILIPPE, DELGORGE CLAIRE, MENET CHRISTINE, POUGHON GILLES, RAVINET-TRILLOU CHRISTINE.

· 2008-04-16

4-CYCLOPROPYLMETHOXY-N-(3.5-DICHLORO-1-OXIDOPYRIDIN-4-YL)-5-(METHOXY)PYRIDINE-2-CARBOXAMIDE'NİN PARKINSON'UN HASTALIKLARINA İLGİLİ ARAŞTIRMASI İÇİN KULLANIMI

USE OF 4-CYCLOPROPYLMETHOXY-N-(3,5-DICHLORO-1-OXIDOPYRIDIN-4-YL)-5-(METHOXY)PYRIDINE-2-CARBOXAMIDE FOR THE TREATMENT OF MOTOR DISORDERS RELATED TO PARKINSON'S DISEASE

DELAY-GOYET PHILIPPE, DELGORGE CLAIRE, MENET CHRISTINE, POUGHON GILLES, RAVINET-TRILLOU CHRISTINE.

· 2008-04-16

4-CYCLOPROPYLMETHOXY-N-(3,5-DICHLORO-1-OKSIDOPYRIDIN-4-YL)-5-(METHOXY)PYRIDINE-2-CARBOXAMIDE'NİN MOTOR Dİ ⁇ ERLERİNİN PARKINSON'UN HASTALIKLARINA İLGİLİ ÇÖZÜMÜ İÇİN KULLANIMI

USE OF 4-CYCLOPROPYLMETHOXY-N-(3,5-DICHLORO-1-OXSIDOPYRIDIN-4-YL)-5-(METHOXY)PYRIDINE-2-CARBOXAMIDE FOR THE TREATMENT OF MOTOR DISORDERS RELATED TO PARKINSON'S DISEASE

DELAY-GOYET PHILIPPE, DELGORGE CLAIRE, MENET CHRISTINE, POUGHON GILLES, RAVINET-TRILLOU CHRISTINE.

· 2008-04-16

Parkinson hastalığının erken dönemlerinde dopamin agonist tedavisi.

Dopamine agonist therapy in early Parkinson's disease.

Stowe RL, Ives NJ, Clarke C, van Hilten J, Ferreira J, Hawker RJ, Shah L, Wheatley K, Gray R.

Cochrane Database Syst Rev · 2008-04-16

DOI: 10.1002/14651858.cd006564.pub2PMID: 18425954

DEXTROTATORY AMINO'DAN PEPTİDOMİMETİK AJENLER, NEURODEGENERATİF HASTALIKLARIN TEDAVİSİ İÇİN SONUÇU KORUYAN FARMAKAJİTİK AJENLER kadar iyi.

PEPTIDOMIMETIC AGENTS FROM DEXTROROTATORY AMINO ACIDS AS WELL AS PHARMACEUTICAL AGENTS THAT CONTAIN THE LATTER FOR TREATMENT OF NEURODEGENERATIVE DISEASES

WINDISCH MANFRED, HUTTER-PAIER BIRGIT, WRONSKI ROBERT.

· 2008-04-14

SYNUCLEINOPATHIES'İN TEDAVİSİNDE SYCLOHEXANEHEXOL DERİVATİFLERİNİN KULLANIMI

USE OF CYCLOHEXANEHEXOL DERIVATIVES IN THE TREATMENT OF a-SYNUCLEINOPATHIES

MCLAURIN JOANNE.

· 2008-04-11